Learn and Connect with C5’s Life Sciences IP Portfolio Advisory Board:
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.

Monika Dorda

SVP & General Counsel Global Pharmaceuticals
GSK

Sabrina Duschner

Head of Patent Litigation Strategy
Fresenius Kabi

Bert Oosting

Partner
Hogan Lovells

Co-Chairs’ Opening Remarks

May 31, 2022 9:00 am

Guido Pontremoli, Ph.D.

Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.

Laura Reynolds

Associate General Counsel
European IP and Regulatory Litigation
Teva Pharmaceuticals

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron UK Ltd